Jamey Marth awarded $13.5 million by NIH to investigate the pathogenesis and treatment of sepsis

The grant was awarded to Marth to continue his team’s groundbreaking research on the molecular mechanisms of sepsis with the goal of achieving more effective treatments.

Peter Adams and Gerald Shadel awarded $13 million from NIH to study aging and liver cancer

A new grant awarded to faculty from Sanford Burnham Prebys and the Salk Institute will fund a five-year project to explore the connection between aging and liver cancer with the goal of developing new therapeutic approaches.

NASA awards $2 million to study effects of low gravity on muscle and neuron function

The three-year grant to assistant professor Karen Ocorr will study the model organisms of fruit flies and nematode worms aboard the International Space Station.

Chemical biologist Eric Wang joins Sanford Burnham Prebys

Eric Wang, Ph.D., has joined our NCI-designated Cancer Center an assistant professor in the Tumor Initiation and Maintenance Program. His lab will focus on using and developing chemical tools to influence the activity of tumor and immune cells.

Endeavor Biomedicines licenses ULK1/2 inhibitor from Sanford Burnham Prebys and the Salk Institute

The exclusive agreement with Endeavor Biomedicines is for an intellectual property portfolio relating to cancer therapeutics and diagnostics that target ULK1/2, a protein involved in cell recycling.